Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia

European Journal of Pharmacology

Volumn 295, Issue 2-3, 1996, Pages 147-154

  Kafka, Sharon H ^a   Corbett, Roy ^a  

^a SANOFI   (France)

Author keywords

Adenosine receptor agonist; Behavioral interaction; Catalepsy; Dopamine receptor antagonist; Schizophrenia

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 (3 CHLOROSTYRYL)CAFFEINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; 8 PHENYLTHEOPHYLLINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR AFFECTING AGENT; APOMORPHINE; CYCLOHEXYLADENOSINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR AFFECTING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; RACLOPRIDE; ADENOSINE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CATALEPSY; CLIMBING; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENCY; DRUG SELECTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; ANIMAL BEHAVIOR; CLASSIFICATION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; WISTAR RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; CATALEPSY; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; SCHIZOPHRENIA;

EID: 0029671207     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00668-0     Document Type: Article

References (38)

1. Abbracchio, M.P., F. Cattabeni, B.B. Fredholm and M. Williams, 1993, Purinoceptor nomenclature: a status report, Drug Dev. Res. 28, 207.
2. Agnati, L.F., K. Fuxe, F. Benfenati, G. Von Euler and B. Fredholm, 1993, Intramembrane receptor-receptor interactions: integration of signal transduction pathways in the nervous system, Neurochem. Int. 22(3), 213.
3. 2a receptors in the nucleus accumbens mediate locomotor depression, Brain Res. Bull. 31, 397.
4. 3H]NECA in rat striatal membranes, Mol. Pharmacol. 29, 331.
5. Corbett, R., H. Hartman, L.L. Kerman, A.T. Woods, J.T. Strupczewski, G.C. Helsley, P.C. Conway and R.W. Dunn, 1993. Effects of atypical antipsychotic agents on social behavior in rodents, Pharmacol. Biochem. Behav. 45, 9.
6. Costall, B., R.J. Naylor and V. Nohria, 1978, Climbing behavior induced by apomorphine in mice: a potent model for the detection of neuroleptic activity, Eur. J. Pharmacol. 50, 39.
7. Dunn, R.W., D.M. Flanagan, L.L. Martin, L.L. Kerman, A. T. Woods, F. Camacho, C.A. Wilmot, M.L. Cornfeldt, R.C. Effland, P.L. Wood and R. Corbett, 1992, Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents, Eur. J. Pharmacol. 214, 207.
8. 3 antagonists ondansetron, zacopride, 3α-tropanyl-1H-indole-3-carboxylic acid ester, and 1αH,3α,5αH-tropan-3-yl-3,5- dichlorobenzoate, Drug Dev. Res. 23, 289.
9. 2 receptor involvement in the hypomobility effects of adenosine analogues in mice, Eur. J. Pharmacol. 168, 285.
10. 2 receptors in rat striatal membranes, Proc. Natl. Acad. Sci. USA 88, 7238.
11. 2 receptors induces catalepsy, Neurosci. Lett. 130, 162.
12. Ferré, S., W.T. O'Connor, K. Fuxe and U. Ungerstedt, 1993, The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain, J. Neurosci. 13(12), 5402.
13. 2 receptors in the neostriatum, Psychopharmacology 116, 279.
14. 2 dopamine receptors in rat striatum, Mol. Brain Res. 14, 186.
15. Fredholm, B.B. and T.V. Dunwiddie, 1988, How does adenosine inhibit transmitter release?, Trends Pharmacol. Sci. 9, 130.
16. Fredholm, B.B., B. Johansson, I. Van der Ploeg, P.S. Hu and S. Jin, 1993, Neuromodulatory roles of purines, Drug Dev. Res. 28, 349.
17. 2 receptor interactions in the striatum as a basis for adenosine/dopamine interactions in the central nervous system, Drug Dev. Res. 28, 374.
18. Heffner, T.G., J.N. Wiley, A.E. Williams, R.F. Bruns, L.L. Coughenour and D.A. Downs, 1989, Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice, Psychopharmacology 98, 31.
19. 2-selective adenosine antagonists, J. Med. Chem. 36, 1333.
20. 2-adenosine antagonist in vitro and in vivo, FEBS Lett. 323(1-2), 141.
21. 2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices, J. Pharmacol. Exp. Ther. 267(1), 801.
22. Kane, J.M., G. Honigfeld, J. Singer and H.Y. Meltzer, 1988, Clozapine for the treatment-resistant schizophrenic, Arch. Gen. Psychiatry 45, 789.
23. Litchfield, L. and F. Wilcoxon, 1949, A simplified method of evaluating dose effect experiments, J. Pharmacol. Exp. Ther. 96, 99.
24. Maenhaut, C., J. Van Sande, F. Libert, M. Abramowicz, M. Parmentier, J.-J. Vanderhaegen, J.E. Dumont, G. Vassart and S. Schiffmann, 1990, RDC8 codes for an adenosine Areceptor with physiological constitutive activity, Biochem. Biophys. Res. Commun. 173(3), 1169.
25. 1 adenosine receptor from rat brain, Mol. Pharmacol. 40, 1.
26. Meshul, C.K., R.K. Stallbaumer, B. Taylor and A. Janowsky, 1994, Haloperidol-induced morphological changes in striatum are associated with glutamate synapses, Brain Res. 648, 181.
27. Mesotten, F., E. Suy, M. Pietquin, P. Burton, S. Heylen and Y. Gelders, 1989, Therapeutic effect and safety of increasing doses of risperidone (R64744) in psychotic patients, Psychopharmacology 99, 445.
28. Mileson, B.E., M.H. Lewis and R.B. Mailman, 1991, Dopamine receptor 'supersensitivity' occurring without receptor up-regulation, Brain Res. 561, 1.
29. Morelli, M. and G. Di Chiara, 1985, Catalepsy induced by SCH 23390 in rats, Eur. J. Pharmacol. 117, 179.
30. 2 receptors in unilaterally 6-hydroxydopamine- lesioned rats, Eur. J. Pharmacol. 251, 21.
31. Rupniak, N.M.J., S. Mann, M.D. Hall, S. Fleminger, G. Kilpatrick, P. Jenner and C.D. Marsden, 1984, Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat, Psychopharmacology 84, 503.
32. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study, J. Neurochem, 57(3), 1062.
33. 2a receptor expression in striatal neurons: implications for basal ganglia pathophysiology, Drug Dev. Res. 28, 381.
34. Schwabe, U., T. Fein and A. Lorenzen, 1993, Pharmacological properties of adenosine receptors and adenosine binding proteins, Drug Dev. Res. 28, 220.
35. Snyder, S.H., 1985, Adenosine as a neuromodulator, Annu. Rev. Neurosci. 8, 103.
36. 2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873), J. Med. Chem. 38(7) 1119.
37. Tallarida, R.J. and R.B. Murray (eds.), 1987, Manual of Pharmacological Calculations with Computer Programs (Springer-Verlag, New York) p. 10, p. 153.
38. 3 adenosine receptor, Proc. Natl. Acad. Sci. USA 89, 7432.